questions
Learning Objectives
- Name the causative agent for lymphogranuloma venereum
- Describe the characteristic clinical manifestations associated with lymphogranuloma venereum
- Discuss diagnostic approach for a person with suspected lymphogranuloma venereum
- List CDC-recommended regimens and duration of therapy for treatment of lymphogranuloma venereum
- Summarize CDC-recommended treatment regimens for lymphogranuloma venereum during pregnancy
Authors
Chase A. Cannon, MD, MPH
Chase A. Cannon, MD, MPH
Acting Assistant Professor
Division of Allergy and Infectious Diseases
University of Washington
Acting Assistant Professor
Division of Allergy and Infectious Diseases
University of Washington
Disclosures: None
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Editor-in-Chief, National STD Curriculum
Division of Allergy and Infectious Diseases
University of Washington
Professor of Medicine
Editor-in-Chief, National STD Curriculum
Division of Allergy and Infectious Diseases
University of Washington
Disclosures: None
Reviewers
Aley G. Kalapila, MD, PhD
Aley G. Kalapila, MD, PhD
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health System
Disclosures: None
th Edition
This is a substantial revision of the original Question Bank Topic. The previous edition was titled Lymphogranuloma venereum and available until October 5th, 2021.
Explore this topic in detail in the Lymphogranuloma venereum (LGV) Quick Reference,
or earn more CE for it in the Lymphogranuloma venereum (LGV) Self-Study
or earn more CE for it in the Lymphogranuloma venereum (LGV) Self-Study